AI Visibility Scorecard
Oncotype DX Breast Recurrence Score® Test for Patients
geneticsvsgenomics.com · Healthcare
Somewhat visible. AI bots can read Oncotype DX Breast Recurrence Score® Test for Patients, but it is missing the structured signals that push citation rate above competitors.
AI engines read this profile 8 times
Meta AI · Claude
#229,740 of 919,067 in Healthcare for AI visibility
5
AEO Visibility
iBorderline · 5.3/10
0
Muse Index Score
iAI agent readiness
Not agent-ready · 0/100
0
AI Adoption
iNone detected · 0/100
About Oncotype DX Breast Recurrence Score® Test for Patients
from our crawl and measurement
Oncotype DX Breast Recurrence Score® Test for Patients, based in Madison, WI, describes itself simply: "The Oncotype DX Breast Recurrence Score Test helps determine distant recurrence and is predictive of chemotherapy benefit." To AI engines like ChatGPT and Perplexity it is partially visible, scoring 5.3 out of 10, readable in places and missing in others.
Our crawl found a readable heading structure. It is missing structured data describing the business, an llms.txt file and a sitemap.
AI crawlers have visited once in our tracking, including ClaudeBot (Anthropic).
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Strong
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Fair
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Strong
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 5.3/10, Oncotype DX Breast Recurrence Score® Test for Patients has a working base to build on - fixable, and the signals above are where to start.
Frequently Asked Questions
How likely is my cancer to come back? Will chemotherapy help?
Every patient is different and so is every tumor. The Breast Recurrence Score test uses The study of the complete set of DNA (including all of its genes) in a person or other organism.genomic information to give you and your doctor important risk information about how your individual tumor will likely behave.
Is this test right for me?
If you’ve been diagnosed with HR+, HER2- invasive breast cancer, the Oncotype DX Breast Recurrence Score test may offer you valuable insights to help guide your treatment decisions.
What happens once your doctor orders your test?
Your Breast Recurrence Score test is performed on tumor tissue that’s already been removed from your breast during your biopsy or at the time of surgery.
Is this your brand?
The exact fixes for Oncotype DX Breast Recurrence Score® Test for Patients
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Oncotype DX Breast Recurrence Score® Test for Patients.
Source & Attribution
Scored by Engagemii on August 1, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/geneticsvsgenomics
Cite this score: Engagemii (2026). "AEO Score for Oncotype DX Breast Recurrence Score® Test for Patients." Retrieved from https://engagemii.com/aeo/brands/geneticsvsgenomics
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform